173 related articles for article (PubMed ID: 14639551)
21. Two distinct types of non-specific immunosuppression in murine malaria.
Lelchuk R; Playfair JH
Clin Exp Immunol; 1980 Dec; 42(3):428-35. PubMed ID: 7011609
[TBL] [Abstract][Full Text] [Related]
22. Plasmodium yoelii: influence of antimalarial treatment on acquisition of immunity in BALB/c and DBA/2 mice.
Ma SH; Zheng L; Liu YJ; Guo SY; Feng H; Chen G; Li DM; Wang JC; Cao YM
Exp Parasitol; 2007 Jul; 116(3):266-72. PubMed ID: 17336298
[TBL] [Abstract][Full Text] [Related]
23. Concurrent infection with Heligmosomoides polygyrus suppresses anti-Plasmodium yoelii protection partially by induction of CD4(+)CD25(+)Foxp3(+) Treg in mice.
Tetsutani K; Ishiwata K; Ishida H; Tu L; Torii M; Hamano S; Himeno K; Hisaeda H
Eur J Immunol; 2009 Oct; 39(10):2822-30. PubMed ID: 19728313
[TBL] [Abstract][Full Text] [Related]
24. Resistance of regulatory T cells to glucocorticoid-induced [corrected] TNFR family-related protein (GITR) during Plasmodium yoelii infection.
Hisaeda H; Hamano S; Mitoma-Obata C; Tetsutani K; Imai T; Waldmann H; Himeno K; Yasutomo K
Eur J Immunol; 2005 Dec; 35(12):3516-24. PubMed ID: 16304635
[TBL] [Abstract][Full Text] [Related]
25. Plasmodium yoelii: assessment of production and role of nitric oxide during the early stages of infection in susceptible and resistant mice.
Wang QH; Liu YJ; Liu J; Chen G; Zheng W; Wang JC; Cao YM
Exp Parasitol; 2009 Mar; 121(3):268-73. PubMed ID: 19109953
[TBL] [Abstract][Full Text] [Related]
26. Role of TGF-beta and PGE2 in T cell responses during Plasmodium yoelii infection.
Ocaña-Morgner C; Wong KA; Lega F; Dotor J; Borras-Cuesta F; Rodriguez A
Eur J Immunol; 2007 Jun; 37(6):1562-74. PubMed ID: 17474154
[TBL] [Abstract][Full Text] [Related]
27. Methotrexate and aminopterin lack in vivo antimalarial activity against murine malaria species.
Irungu B; Kiboi D; Langat B; Rukunga G; Wittlin S; Nzila A
Exp Parasitol; 2009 Oct; 123(2):118-21. PubMed ID: 19527714
[TBL] [Abstract][Full Text] [Related]
28. The effects of host diet on Plasmodium yoelii nigeriensis.
Ibekwe CA; Ugwunna SC
J Parasitol; 1990 Dec; 76(6):903-12. PubMed ID: 2254825
[TBL] [Abstract][Full Text] [Related]
29. Immunological responses of neonates and infants to DNA vaccines.
Sedegah M; Hoffman SL
Methods Mol Med; 2006; 127():239-51. PubMed ID: 16988458
[TBL] [Abstract][Full Text] [Related]
30. Effects of pyran copolymer on host resistance of mice to Plasmodium yoelii.
Krishna VR; Fouant MM; Bradley SG
J Parasitol; 1989 Jun; 75(3):405-10. PubMed ID: 2723926
[TBL] [Abstract][Full Text] [Related]
31. [Protective immune mechanisms induced by cellular vaccine made of the erythrocytic Plasmodium yoelii].
Yuan J; Xu B; Liu BF
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Feb; 26(1):47-51. PubMed ID: 15052774
[TBL] [Abstract][Full Text] [Related]
32. Effects of p-aminobenzoic acid, methionine, threonine and protein levels on susceptibility of mice to Plasmodium berghei.
Keshavarz-Valian H; Alger NE; Boissonneault GA
J Nutr; 1985 Dec; 115(12):1613-20. PubMed ID: 3934351
[TBL] [Abstract][Full Text] [Related]
33. Resistance to sulphadrug-based antifolate therapy in malaria: are we looking in the right place?
Platteeuw JJ
Trop Med Int Health; 2006 Jun; 11(6):804-8. PubMed ID: 16772001
[TBL] [Abstract][Full Text] [Related]
34. Genetically attenuated parasite vaccines induce contact-dependent CD8+ T cell killing of Plasmodium yoelii liver stage-infected hepatocytes.
Trimnell A; Takagi A; Gupta M; Richie TL; Kappe SH; Wang R
J Immunol; 2009 Nov; 183(9):5870-8. PubMed ID: 19812194
[TBL] [Abstract][Full Text] [Related]
35. Expression of human CD81 differently affects host cell susceptibility to malaria sporozoites depending on the Plasmodium species.
Silvie O; Greco C; Franetich JF; Dubart-Kupperschmitt A; Hannoun L; van Gemert GJ; Sauerwein RW; Levy S; Boucheix C; Rubinstein E; Mazier D
Cell Microbiol; 2006 Jul; 8(7):1134-46. PubMed ID: 16819966
[TBL] [Abstract][Full Text] [Related]
36. Early treatment during a primary malaria infection modifies the development of cross immunity.
Legorreta-Herrera M; Ventura-Ayala ML; Licona-Chávez RN; Soto-Cruz I; Hernández-Clemente FF
Parasite Immunol; 2004 Jan; 26(1):7-17. PubMed ID: 15198641
[TBL] [Abstract][Full Text] [Related]
37. Vitamin E-deficient diets enriched with fish oil suppress lethal Plasmodium yoelii infections in athymic and scid/bg mice.
Taylor DW; Levander OA; Krishna VR; Evans CB; Morris VC; Barta JR
Infect Immun; 1997 Jan; 65(1):197-202. PubMed ID: 8975912
[TBL] [Abstract][Full Text] [Related]
38. Plasmodium Para-Aminobenzoate Synthesis and Salvage Resolve Avoidance of Folate Competition and Adaptation to Host Diet.
Matz JM; Watanabe M; Falade M; Tohge T; Hoefgen R; Matuschewski K
Cell Rep; 2019 Jan; 26(2):356-363.e4. PubMed ID: 30625318
[TBL] [Abstract][Full Text] [Related]
39. Uninfected mosquito bites confer protection against infection with malaria parasites.
Donovan MJ; Messmore AS; Scrafford DA; Sacks DL; Kamhawi S; McDowell MA
Infect Immun; 2007 May; 75(5):2523-30. PubMed ID: 17339356
[TBL] [Abstract][Full Text] [Related]
40. The shiitake mushroom-derived immuno-stimulant lentinan protects against murine malaria blood-stage infection by evoking adaptive immune-responses.
Zhou LD; Zhang QH; Zhang Y; Liu J; Cao YM
Int Immunopharmacol; 2009 Apr; 9(4):455-62. PubMed ID: 19189863
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
